News
10 Jun 2026
JUST Signs Memorandum of Understanding with MS Pharma Pharmaceutical Industry

Jordan University of Science and Technology (JUST) signed on Tuesday 9/6/2026, a Memorandum of Understanding (MoU) with MS Pharma, a leading pharmaceutical company in the MENA region, aiming to strengthen collaboration in training, capacity building, scientific research, and the development of specialized academic programs that support the pharmaceutical industry in Jordan and the region.

The MoU was signed on behalf of the university by Vice President Prof. Basheer Khasawneh, and on behalf of the company by its Executive Vice President, Mr. Samer Jalal, in the presence of Prof. Qusai Al-Balass, Dean of the Faculty of Pharmacy, Dr. Osama Alshogran, Vice Dean, and Dr Sofian Meqdadi, a member of the Faculty of Pharmacy Council.

The agreement provides training opportunities for students in the Pharmaceutical and Biological Manufacturing program which largely depends on Dual Studies and Internship training, helping to enhance their skills and prepare them for the labor market through the integration of academic knowledge with practical training. It also includes organizing joint training courses, workshops, and scientific conferences, as well as the exchange of research and technical expertise in pharmacy, pharmaceutical, and biopharmaceutical manufacturing.

Prof. Khasawneh emphasized that the MoU reflects the university's commitment to building strategic partnerships with the pharmaceutical industry, aligning educational outcomes with labor market needs, and reinforcing Jordan's position as a key player in the pharmaceutical sector. Mr. Samer Jalal, in turn, expressed his pride in collaborating with JUST, praising its leading academic and research role at both the national and regional levels, and affirming the company's commitment to leveraging its expertise and resources to support students and researchers, and to prepare a generation capable of innovation and global competitiveness.

This MoU comes as part of the joint strategy of both parties to foster stronger ties between academic institutions and the pharmaceutical industry, thereby advancing scientific research and promoting sustainable development in the fields of medicine and healthcare.